Bottom line
RYHEX vs FHLC: the short answer
RYHEX (Health Care Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 135 for RYHEX, so beyond the top names it adds exposure RYHEX doesn't have.
FHLC is cheaper at 0.084% vs 1.64% — a difference of $156 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +3.9% for RYHEX (reporting dates differ).
RYHEX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYHEX vs FHLC side by side
| RYHEX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.64% | 0.084% |
| Annual cost per $10k | $164 | $8.4 |
| 10-yr cost on $10k (prospectus) | $2,374 | $108 |
| Max front load | 4.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +8.7% | +2.6% |
| 5-yr return (annualized) | +3.9% | +7.2% |
| 10-yr return (annualized) | +7.1% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $19.4M | $3.3B |
| Number of holdings | 135 | 337 |
| Portfolio turnover | 244% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
23 of RYHEX's top 25 holdings also appear in FHLC's top 25.
| Holding | RYHEX | FHLC |
|---|---|---|
| Eli Lilly & Company | 3.63% | 13.35% |
| Johnson & Johnson | 2.88% | 8.93% |
| Abbvie Inc | 2.52% | 6.42% |
| Unitedhealth Group Inc | 2.22% | 5.44% |
| Merck & Company Inc | 2.04% | 4.66% |
| Thermo Fisher Scientific Inc | 1.61% | 3.09% |
| Amgen Inc | 1.56% | 3.00% |
| Abbott Laboratories | 1.42% | 2.66% |
| Gilead Sciences Inc | 1.39% | 2.34% |
| Vertex Pharmaceuticals Inc | 1.34% | 1.76% |
| Cvs Health Corp | 1.31% | 1.92% |
| Intuitive Surgical Inc | 1.31% | 1.82% |
| Danaher Corp | 1.30% | 1.80% |
| Pfizer Inc | 1.25% | 2.06% |
| Bristol-myers Squibb Company | 1.22% | 1.93% |
Source: SEC Form N-PORT
RYHEX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between RYHEX and FHLC?
Which is cheaper, RYHEX or FHLC?
Should I own both RYHEX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.